Definitive prenatal diagnosis currently relies on invasive techniques, but that may be changing

Diagnostic improvements are key to slowing transmission

As drug test adulteration becomes more sophisticated, so do detection methods

Panels can overcome the challenge of selecting molecular tests for individual pathogens

RT-PCR is considered the gold standard, but certain situations may call for the use of RIDTs

More than half of commercially available glucometers do not meet recommended accuracy guidelines

Clinical utility and cost-effectiveness are key considerations

The immediate and lingering effects on agencies and people

Genetically modified microbes designed to treat human disease have entered into preclinical and clinical development

Large data sets hold promise, but major challenges remain